Compass Therapeutics Inc
(CMPX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2018 | 12-2017 | 12-2005 | 09-2005 | 06-2005 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -35 | N/A | 2,580 | 1,350 | 2,550 |
| Depreciation Amortization | 0 | N/A | 1,030 | 450 | 1,660 |
| Other Working Capital | 0 | N/A | -8,870 | -2,620 | -5,770 |
| Other Operating Activity | 0 | 0 | 620 | 420 | 530 |
| Operating Cash Flow | $-35 | $N/A | $-4,640 | $-400 | $-1,030 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | 0 | N/A | -1,500 | -1,150 | -2,430 |
| Net Acquisitions | 0 | N/A | 0 | 0 | -3,300 |
| Other Investing Activity | 0 | 0 | 0 | -10 | 0 |
| Investing Cash Flow | $0 | $N/A | $-1,500 | $-1,160 | $-5,730 |
| Cash Flows From Financing Activities | |||||
| Other Financing Activity | 35 | 0 | 6,890 | 1,900 | 7,750 |
| Financing Cash Flow | $35 | $N/A | $6,890 | $1,900 | $7,750 |
| Exchange Rate Effect | 0 | N/A | 170 | -170 | -1,130 |
| Beginning Cash Position | 0 | N/A | 3,040 | 3,040 | 3,190 |
| End Cash Position | 0 | N/A | 3,960 | 3,200 | 3,040 |
| Net Cash Flow | $0 | $N/A | $910 | $150 | $-150 |
| Free Cash Flow | |||||
| Operating Cash Flow | -35 | N/A | -4,640 | -400 | -1,030 |
| Free Cash Flow | -35 | 0 | -4,640 | -400 | -1,030 |